Filing Details
- Accession Number:
- 0001104659-23-083442
- Form Type:
- 13G Filing
- Publication Date:
- 2023-07-23 20:00:00
- Filed By:
- Venrock Healthcare Capital Partners Iii, L.p.
- Company:
- Adverum Biotechnologies Inc. (NASDAQ:ADVM)
- Filing Date:
- 2023-07-24
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
| VHCP Co-Investment Holdings III | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
| Venrock Healthcare Capital Partners EG | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
| VHCP Management III | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
| VHCP Management EG | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
| Shah, Nimish | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
| Koh, Bong | 0 | 5,899,489 | 0 | 5,899,489 | 5,899,489 | 5.9% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Adverum Biotechnologies, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
00773U108
(CUSIP Number)
July 14, 2023
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ¨ | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 00773U108 | Page 2 of 17 |
| 1. | Names of Reporting Persons
Venrock Healthcare Capital Partners III, L.P. | ||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b) ¨ | ||
| 3. | SEC Use Only
| ||
| 4. | Citizenship or Place of Organization
Delaware | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power
0 | |
| 6. | Shared Voting Power
5,899,489 (2) | ||
| 7. | Sole Dispositive Power
0 | ||
| 8. | Shared Dispositive Power
5,899,489 (2) | ||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
5,899,489 (2) | ||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
| ||
| 11. | Percent of Class Represented by Amount in Row (9)
5.9% (3) | ||
| 12. | Type of Reporting Person (See Instructions)
PN | ||
| (1) | Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| (2) | Consists of (i) 1,550,976 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 155,152 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 4,193,361 shares held by Venrock Healthcare Capital Partners EG, L.P. |
| (3) | This percentage is calculated based upon 100,574,949 shares of Common Stock outstanding as of May 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 filed with the Securities and Exchange Commission on May 11, 2023. |
| CUSIP No. 00773U108 | Page 3 of 17 |
| 1. | Names of Reporting Persons
VHCP Co-Investment Holdings III, LLC | ||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b) ¨ | ||
| 3. | SEC Use Only
| ||
| 4. | Citizenship or Place of Organization
Delaware | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power
0 | |
| 6. | Shared Voting Power
5,899,489 (2) | ||
| 7. | Sole Dispositive Power
0 | ||
| 8. | Shared Dispositive Power
5,899,489 (2) | ||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
5,899,489 (2) | ||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
| ||
| 11. | Percent of Class Represented by Amount in Row (9)
5.9% (3) | ||
| 12. | Type of Reporting Person (See Instructions)
OO | ||
| (1) | Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| (2) | Consists of (i) 1,550,976 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 155,152 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 4,193,361 shares held by Venrock Healthcare Capital Partners EG, L.P. |
| (3) | This percentage is calculated based upon 100,574,949 shares of Common Stock outstanding as of May 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 filed with the Securities and Exchange Commission on May 11, 2023. |
| CUSIP No. 00773U108 | Page 4 of 17 |
| 1. | Names of Reporting Persons
Venrock Healthcare Capital Partners EG, L.P. | ||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b) ¨ | ||
| 3. | SEC Use Only
| ||
| 4. | Citizenship or Place of Organization
Delaware | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power
0 | |
| 6. | Shared Voting Power
5,899,489 (2) | ||
| 7. | Sole Dispositive Power
0 | ||
| 8. | Shared Dispositive Power
5,899,489 (2) | ||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
5,899,489 (2) | ||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
| ||
| 11. | Percent of Class Represented by Amount in Row (9)
5.9% (3) | ||
| 12. | Type of Reporting Person (See Instructions)
PN | ||
| (1) | Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| (2) | Consists of (i) 1,550,976 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 155,152 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 4,193,361 shares held by Venrock Healthcare Capital Partners EG, L.P. |
| (3) | This percentage is calculated based upon 100,574,949 shares of Common Stock outstanding as of May 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 filed with the Securities and Exchange Commission on May 11, 2023. |
| CUSIP No. 00773U108 | Page 5 of 17 |
| 1. | Names of Reporting Persons
VHCP Management III, LLC | ||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b) ¨ | ||
| 3. | SEC Use Only
| ||
| 4. | Citizenship or Place of Organization
Delaware | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power
0 | |
| 6. | Shared Voting Power
5,899,489 (2) | ||
| 7. | Sole Dispositive Power
0 | ||
| 8. | Shared Dispositive Power
5,899,489 (2) | ||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
5,899,489 (2) | ||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
| ||
| 11. | Percent of Class Represented by Amount in Row (9)
5.9% (3) | ||
| 12. | Type of Reporting Person (See Instructions)
OO | ||
| (1) | Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| (2) | Consists of (i) 1,550,976 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 155,152 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 4,193,361 shares held by Venrock Healthcare Capital Partners EG, L.P. |
| (3) | This percentage is calculated based upon 100,574,949 shares of Common Stock outstanding as of May 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 filed with the Securities and Exchange Commission on May 11, 2023. |
| CUSIP No. 00773U108 | Page 6 of 17 |
| 1. | Names of Reporting Persons
VHCP Management EG, LLC | ||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b) ¨ | ||
| 3. | SEC Use Only
| ||
| 4. | Citizenship or Place of Organization
Delaware | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power
0 | |
| 6. | Shared Voting Power
5,899,489 (2) | ||
| 7. | Sole Dispositive Power
0 | ||
| 8. | Shared Dispositive Power
5,899,489 (2) | ||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person
5,899,489 (2) | ||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
| ||
| 11. | Percent of Class Represented by Amount in Row (9)
5.9% (3) | ||
| 12. | Type of Reporting Person (See Instructions)
OO | ||
| (1) | Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| (2) | Consists of (i) 1,550,976 shares held by Venrock Healthcare Capital Partners III, L.P.; (ii) 155,152 shares held by VHCP Co-Investment Holdings III, LLC; and (iii) 4,193,361 shares held by Venrock Healthcare Capital Partners EG, L.P. |
| (3) | This percentage is calculated based upon 100,574,949 shares of Common Stock outstanding as of May 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 filed with the Securities and Exchange Commission on May 11, 2023. |
| CUSIP No. 00773U108 | Page 7 of 17 |
| 1. | Names of Reporting Persons
Shah, Nimish | ||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) | ||